21:03 , Jan 27, 2017 |  BC Week In Review  |  Financial News

BioVie completes private placement

Liver disease company BioVie Inc. (Pink:BIVI) raised $200,000 through the sale of 1 million shares at $0.20 on Jan. 4 under a new, 30-month stock purchase agreement with Aspire Capital Fund for up to $12...
07:00 , May 12, 2014 |  BC Week In Review  |  Financial News

NanoAntibiotics financial update

NanoAntibiotics began trading on the Pink Sheets under the symbol "NNAB." The company was not publicly traded prior to the listing. NanoAntibiotics Inc. (Pink: NNAB), Surfside, Fla.   Business: Infectious   Date announced: 5/5/14  ...
07:00 , Apr 21, 2014 |  BC Week In Review  |  Clinical News

NanoAntibiotics preclinical data

In Staphylococcus epidermis bacteria incubated in vitro with tracer dye to monitor the bacteria's membrane transport systems, NanoAntibiotics' efflux pump inhibitor inhibited expulsion of dye, while no dye retention was observed in untreated bacteria. According...